Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

Not Applicable

Recruiting

Conditions: Prostate Cancer

Interventions: Diagnostic Test: PSMA-PET CT

First Posted Date: 2023-07-17

Last Posted Date: 2025-03-11

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 200

Registration Number: NCT05948657

Locations: 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
UCSF, San Francisco, California, United States
🇺🇸
Weill Cornell Medicine - New York Presbyterian Hospital, New York, New York, United States

and more 1 locations

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

Not Applicable

Recruiting

Conditions: Rectal Cancer

Interventions: Radiation: Short Course Radiation Therapy (scRT)
Procedure: Total Mesenteric Excision (TME)

First Posted Date: 2023-07-13

Last Posted Date: 2024-08-07

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 25

Registration Number: NCT05943210

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States
🇺🇸
The University of Chicago, Chicago, Illinois, United States

and more 2 locations

Omuyambi: Traditional Healer Support to Improve HIV Viral Suppression in Rural Uganda

Not Applicable

Recruiting

Conditions: HIV Infections

Interventions: Behavioral: Omuyambi
Behavioral: Control

First Posted Date: 2023-07-13

Last Posted Date: 2025-05-16

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 650

Registration Number: NCT05943548

Locations: 🇺🇬
Mbarara University of Science and Technology, Mbarara, Uganda

A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

Phase 1

Recruiting

Conditions: B-Cell Lymphoma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma

Interventions: Drug: Tazemetostat Pill

First Posted Date: 2023-07-07

Last Posted Date: 2023-10-10

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT05934838

Locations: 🇺🇸
Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York, United States

Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality

Not Applicable

Recruiting

Conditions: Depressive Disorder
Major Depressive Disorder
Depression
Suicidal Ideation

Interventions: Behavioral: Symptom Review and Psychoeducation (SRP)
Behavioral: "Engage & Connect" Psychotherapy

First Posted Date: 2023-06-29

Last Posted Date: 2025-04-24

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 128

Registration Number: NCT05925322

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States

The Effect of Posterior Pericardiotomy on the Incidence of Atrial Fibrillation After Cardiac Surgery-Extended Follow-Up

Completed

Conditions: Atrial Fibrillation

Interventions: Other: Non-Interventional

First Posted Date: 2023-06-15

Last Posted Date: 2025-01-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 420

Registration Number: NCT05903222

Locations: 🇺🇸
Weill Cornell Medical College Department of Cardiothoracic Surgery, New York, New York, United States

Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals

Not Applicable

Recruiting

Conditions: Perinatal Anxiety
Perinatal Depression

First Posted Date: 2023-06-09

Last Posted Date: 2024-08-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 50

Registration Number: NCT05897619

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Naptumomab Estafenatox in Combination With Pembrolizumab Preceded by Obinutuzumab in Patients With Urothelial Cancers

Phase 1

Withdrawn

Conditions: Urothelial Carcinoma

Interventions: Drug: Naptumomab Estafenatox
Drug: Pembrolizumab
Drug: Obinutuzumab

First Posted Date: 2023-06-08

Last Posted Date: 2024-04-12

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT05894447

Locations: 🇺🇸
Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York, New York, United States

Mobile Cognitive Behavioral Therapy for Medical and Graduate Students

Not Applicable

Terminated

Conditions: Anxiety Disorders
Depression

Interventions: Behavioral: Clinician Delivered CBT
Behavioral: Supplemental MAYA App

First Posted Date: 2023-04-21

Last Posted Date: 2025-02-27

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4

Registration Number: NCT05823922

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coordination

Not Applicable

Completed

Conditions: Myocardial Infarction
Transient Ischemic Attack
Cardiovascular Diseases
Atrial Fibrillation
Heart Failure
Hyperlipidemias
Hypertension
Ischemic Heart Disease
Stroke
Diabetes Mellitus

Interventions: Behavioral: Care coordination delivered based on perceived need
Behavioral: Care coordination delivered based on usual care (e.g. discharge from hospital)

First Posted Date: 2023-04-19

Last Posted Date: 2024-07-22

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 400

Registration Number: NCT05820295

Locations: 🇺🇸
New York Presbyterian Hospital - Weill Cornell Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy